Health
New anti-cancer drug breakthrough for prostate cancer – Mirage News
Novel anti-cancer agents induce the degradation of the c-Met oncoprotein in the lysosome as demonstrated by confocal microscopy in tumour cells A new…
A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis (tumour spread) and drug resistance.
Developed by Griffith University researcher Professor Des Richardson and colleagues from the University of Sydney, the drug known as DpC inhibits prostate specific antigen (PSA) as well as suppressing both androgen-dependent and independent arms of androgen receptor signalling.
“The current gold standard for prostate cancer treatment …
-
General22 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
Noosa News22 hours agoHeartbreaking CCTV shows father and son moments before fatal crash in Regents Park, Queensland
-
Business24 hours agoMacquarie predicts more than 40% upside for this ASX 200 stock
-
Noosa News21 hours agoFamily’s heartbreak after Trevor Doyle found dead in park in Logan